A WHO-backed study reveals that overweight postmenopausal women with heart disease face a 31 per cent higher breast cancer ...

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...

Zuellig Pharma, a leading healthcare solutions provider in Asia, is organizing the "Obesity is a Disease" seminar as part of ...

Obesity and heart failure often go together, making treatment more complicated. Now, health experts have released new ...

This precision in risk prediction allows for targeted interventions, potentially reducing unnecessary treatments and improving clinical outcomes.

Obesity in itself is not a contraindication to radical prostatectomy, but it remains a risk factor for poor overall survival. Although obesity increases the technical complexity of radical ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reduction ...

The number of overweight and obese adults in India is expected to rise from 180 million in 2021 to an 449 million by 2050.

Denmark: Following a recent World Health Organization (WHO) alert on semaglutide-containing medicines, Novo Nordisk has ...